# Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors

> **NCT06639256** · PHASE1,PHASE2 · RECRUITING · sponsor: **Sichuan Huiyu Pharmaceutical Co., Ltd** · enrollment: 258 (estimated)

## Conditions studied

- Safety
- Tolerability
- Efficacy

## Interventions

- **DRUG:** Test Product HY07121

## Key facts

- **NCT ID:** NCT06639256
- **Lead sponsor:** Sichuan Huiyu Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-24
- **Primary completion:** 2026-05
- **Final completion:** 2026-10
- **Target enrollment:** 258 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06639256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06639256, "Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06639256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*